Executive Committee

DEINOVE benefits from an experienced management team in research, development, finance and business development, a panel of high-level scientific experts and a Board of Directors highly qualified in the development of drugs and specialty compounds. This organization enables DEINOVE to develop an effective strategy that is relevant to the environment in which it operates.

Alexis Rideau, Chief Executive Officer

PhD in Molecular and Cellular Biology, European Magister in Genetics, MBA

Michael Mourez, Chief Innovation Officer

École Polytechnique, PhD in fundamental bacteriology


Mario Alcaraz, Chief Financial and Administrative Officer

Master in Management Sciences and Management Control, Diploma in Accounting & Management, MBA

Georges Gaudriault

Georges Gaudriault, Chief Scientific Officer

PhD in molecular pharmacology

Dr Yannick Plétan, Chief Medical Officer

MD, MSc, FFPM, Harvard Business School, HEC

Johane Rinaldi, Chief Human Resources Officer

University of Lyon 2, University of Bordeaux 3

Scroll to Top